Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells

Marta Di Martile(Istituti di Ricovero e Cura a Carattere Scientifico), Daniela Trisciuoglio(Institute of Molecular Biology and Pathology)
Oncotarget
February 8, 2016
Cited by 54


Related Papers